| 21/108 | US=2 / Farmacologia Fluxe K, Marcellino D, Guidolin D, Woods A, Agnati L. Dopamine receptor oligomerization. In: Neve KA. The dopamine receptors. 2ªed. New York: Humana Press, 2009. p. 255-80. ISBN 978-1-60327-332-9. RECEPTOR DE DOPAMINA; OLIGOMERIZACAO; SUBTIPOS DE RECEPTORES DE DOPAMINA; RECEPTOR INTERACOES; HOMOMERS DOPAMINA; MOSAICO RECEPTOR; COOPERATIVIDADE; ACOPLADOS RECEPTORES DE PROTEINA G; RECEPTORES DE CANAL IONICO; QUINASE DO RECEPTOR TIROSINA |
| 22/108 | US=7 / Gastro Folprecht G. Biologicals for colorectal cancer metastases. In: Vauthey JN, Hoff PMG, Audisio RA, Poston GJ. Liver metastases. New York: Springer, 2009. p. 91-7. ISBN 978-1-84628-946-0. CANCER COLORRETAL; RECEPTORES DE FATOR DE CRESCIMENTO EPIDERMICO (EGFR); TOXICIDADE; INIBIDORES DE TIROSINA-QUINASE; TERAPIA ANTI-ANGIOGENETICA |
| 23/108 | US=6 / Quimioterapia Airley R. Tyrosine kinase inhibitors. In: ___. Cancer chemotherapy: basic science to the clinic. New Jersey: John Wiley & Sons, 2009. p. 217-23. ISBN 978-0-470-09254-5. INIBIDORES DA QUINASE DE TIROSINA; NAO-RECEPTOR INIBIDORES DE TIROSINA |
| 24/108 | US=22 / Urologia Lam JS, Figlin RA, Belldegrum AS,. VEGF: and PDGF receptors: biologic relevance and clinical approaches to inhibition. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 119-49. ISBN 978-1-58829-737-2. DERIVADO DE PLAQUETAS FACTOR DE CRESCIMENTO; RECEPTORES; TRANSDUCAO DE SINAL; TIROSINA-QUINASE; FACTOR DE CRESCIMENTO ENDOTELIAL VASCULAR |
| 25/108 | US=22 / Urologia Kawabe M, Herrem CJ, Finke JH, Storkus WJ. EphA2: a novel target in renal cell carcinoma. In: Bukowski RM, Figlin RA, Motzer RJ. Renal cell carcinoma: molecular targets and clinical applications. 2ªed. New York: Humana Press, 2009. p. 347-66. ISBN 978-1-58829-737-2. RTK; CD8+ T LINFOCITOS; QUINASE DE TIROSINA RECEPTORA; PROTEASSOMA; TERAPIA COMBINATORIA; COMPLEXO PRINCIPAL DE HISTOCOMPATIBILIDADE |
| 26/108 | US=27 / Clin/Médica Golan DE. Anemias hemolíticas: defeitos da membrana e do metabolismo dos eritrócitos. In: Goldman L, Ausiello D, editors. Cecil medicina. 23ª ed. Rio de Janeiro: Elsevier, 2009. p. 1385-95. ISBN 85-3523677-4. MEMBRANA ERITROCITICA. ANATOMIA; MEMBRANA ERITROCITICA. FISIOLOGIA; ESFEROCITOSE HEREDITARIA; ELIPTOCITOSE HEREDITARIA; XEROCITOSE HEREDITARIA; ESTOMATOCITOSE HEREDITARIA; DEFICIENCIA DE GLICOSE-6-FOSFATO DESIDROGENASE; DEFICIENCIA DE PIRUVATO QUINASE |
| 27/108 | US=45 / Clín/Médica Maruta H, Ohta T. Signal therapy: propolis and Pepper extracts as cancer therapeutics. In: Watson RR, editor. Complementary and alternative therapies in the agind population. Amsterdan: Elsevier, 2009. p. 523-39. ISBN 978-0-12-374228-5. TERAPIA DE SINAL; EXTRATOS DE PIMENTA. TRATAMENTO DO CANCER; PROPOLIS. TRATAMENTO DO CANCER; SINALIZAR; TERAPEUTICO; CANCER; NEUROFIBROMATOSE; PAK1; QUINASE; PROPOLIS; PIMENTA |
| 28/108 | US=50 / Câncer Heckman CA, Holopainen T, Alitalo K. Molecular targeting of lymphangiogenesis and tumor metastasis. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 283-95. ISBN 978-1-60327-086-1. LINFANGIOGENESE; METASTASE LINFATICA; MOLECULAS LINFANGIOGENICAS; INIBIDORES DA QUINASE DE TIROSINA; RECEPTORES SOLUVEIS; ANTICORPOS BLOQUEADORES |
| 29/108 | US=50 / Câncer Berz D, McCormack E, Mega A, Wanebo HJ. Targeting signaling pathways in cancer therapy. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 309-26. ISBN 978-1-60327-086-1. EGFR; RECEPTOR DO FATOR DE CRESCIMENTO EPITELIAL; INIBIDORES DA QUINASE DE TIROSINA; MOLECULAS PEQUENAS; SOLIDAS MALIGNAS DE TUMORES; TERAPIA-ALVO; PREDITORES DE RESPOSTA; CANCER DE MAMA; CARCINOMA HEPATOCELULAR; CANCER DE PULMAO; CANCER DE COLON |
| 30/108 | US=50 / Câncer Karrim J, Dubey S. Advances in the treatment of lung cancer. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 545-52. ISBN 978-1-60327-086-1. TRATAMENTO DO CANCER DO PULMAO; NEOPLASIAS PULMONARES; QUIMIOTERAPIA; ADJUVANTE; MARCADORES BIOLOGICOS; ANGIOGENESE; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; INIBIDORES DA PROTEINA QUINASE; ANTICORPOS MONOCLONAIS; RADIOTERAPIA |
| 31/108 | US=85 / Biol/Mol Corazza N, Kassahn D, Jakob S, Badmann A, Brunner T. TRAIL-induced apoptosis: between tumor therapy and immunopathology. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 50-8. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. TRAIL; HEPATOCITOS; APOPTOSE; TUMOR; LESAO HEPATICA; BIM; JUN QUINASE |
| 32/108 | US=85 / Biol/Mol Jang YJ, Kim JE, Kang NJ, Lee KW, Lee HJ. Piceatannol attenuates 4-hydroxynonenal-induced apoptosis of PC12 cells by blocking activation of c-Jun N-terminal kinase. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 176-82. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. APOPTOSE; BCL-2; APOPTOSE; 4-HIDROXINONENAL; C-JUN N-TERMINAL QUINASE; PICEATANNOL |
| 33/108 | US=85 / Biol/Mol Wesierska-Gadek J, Krystof V. Selective cyclin-dependent kinase inhibitors discriminating between cell cycle and transcriptional kinases: future reality or utopia?. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 228-41. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. CICLO CELULAR; CYC202; CICLINA-QUINASE DEPENDENTE; P53; ROSCOVITINA; TRANSCRICAO |
| 34/108 | US=89 / Biol/Mol Barzon L, Pacenti M, Franchin E, Colombo F, Palu G. HSV-tk/IL-2 gene therapy for glioblastoma multiforme. In: Walther W, Stein US. Gene therapy of cancer: methods and protocols. 2ª ed. New Jersey: Humana Press, 2009. p. 529-49. (Methods in Molecular Biology, 542) ISBN 978-1-59745-561-9. TERAPIA GENETICA; HSV-TK/IL-2; GLIOBLASTOMA MULTIFORME; ENSAIO CLINICO; INTERLEUCINA-2; VETOR RETROVIRAL; GENE SUICIDA; TIMIDINA QUINASE |
| 35/108 | US=85 / Biol/Mol Kang MK, Kang NJ, Jang YJ, Lee KW, Lee HJ. Gallic acid induces neuronal cell death through activation of c-jun n-terminal kinase and downregulation of Bcl-2. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 514-20. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5. |
| 36/108 | US=96 / Biol/Mol Bulun SE, Lin Z, Zhao H, Lu M, Amin S, Reierstad S, Chen D. Regulation of aromatase expression in breast cancer tissue. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 121-31. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0. BRCA-1; ARF; CREB; AROMATASE; CANCER DE MAMA; PROSTAGLANDINA E2; JUNHO QUINASE; P38 QUINASE; RECEPTOR DE ESTROGENIO-&*945;; INIBIDOR DA AROMATASE |
| 37/108 | US=108 / Câncer Schepelmann S, Hedley D, Ogilvie LM, Springer CJ. Gene-directed enzyme prodrug therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 255-76. ISBN 978-0-470-01922-1. TERAPIA GENICA; PRO-DROGA; PRO-FARMACO ATIVADO POR ENZIMA; GANCICLOVIR; TIMIDINA QUINASE; 5-FLUOROCITOSINA; CITOSINA DEAMINASE; CB1954; NITRORREDUTASE; CARBOXIPEPTIDASE G2; OXAZAPHOSPHORINES; CITOCROMO P450; FLUDARABINA; PURINA NUCLEOSIDEO FOSFORILASE; SELENOMETIONINA; METIONINASE; CPT-11; CARBOXILESTERASE; RETROVIRUS; ADENOVIRUS; VACCINIA; VIRUS HERPES SIMPLEX; VIRUS SINDBIS |
| 38/108 | US=108 / Câncer Veerapong J, Bickenbach KA, Weichselbaum RR. Radiosensitization in viral gene therapy. In: Harrington KJ, Vile RG, Pandha HS. Viral therapy of cancer. New Jersey: John Wiley & Sons, 2008. p. 313-26. ISBN 978-0-470-01922-1. TERAPIA GENICA; RADIOSENSIBILIZACAO; ADENOVIRUS; VIRUS HERPES SIMPLEX; TIMIDINE QUINASE; CITOSINA DEAMINASE; NITRORREDUTASE; CITOCROMO P450; TERAPIA DE GENE SUICIDA |
| 39/108 | US=11-B / Quimioterapia Kingsley CD. Hypersensitivity reactions. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 152-73. ISBN 978-0-7817-7328-7. REACOES DE HIPERSENSIBILIDADE; ASPARAGINASE; PEGASPARGASE; PACLITAXEL; DOCETAXEL; TENIPOSIDE; ETOPOSIDE; CISPLATINA; CARBOPLATINA; OXALIPLATINA; PROCARBAZINE; CITARABINA; ANTRACICLINA; CICLOFOSFAMIDA; IFOSFAMIDA; MELFALANO; CLORAMBUCIL; TIOTEPA; METOTREXATO; TRIMETREXATO; PEMETREXED; 5-FLUOROURACIL; CAPECITABINA; GEMCITABINA; MITOXANTRONA; MITOMICINA; BLEOMICINA; VINCRISTINA; VINBLASTINA; VINORELBINA; FLUDARABINA; CLADRIBINA; PENTOSTATINA; HIDROXIUREIA; IRINOTECAM; TOPOTECANO; DACARBAZINA; TEMOZOLAMIDA; 6-MERCAPTOPURINA; ALDESLEUCINA; DENILEUCINA DIFTITOX; INTERFERON ALFA; ANTICORPOS MONOCLONAIS; TIROSINA-QUINASE; INIBIDORES PROTEOSSOMICOS; TALIDOMIDA; LENALIDOMIDA; TERAPIA HORMONAL; FATORES DE CRESCIMENTO HEMATOPOETICOS |
| 40/108 | US=11-B / Quimioterapia Floyd JD, Perry MC. Cardiotoxicity of cancer therapy. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 179-90. ISBN 978-0-7817-7328-7. CANCER. TERAPIA; CARDIOTOXICIDADE; ANTIBIOTICOS ANTITUMORAIS; ANTRACICLINA; ANTRAQUINOIDES; MITOMICINA C; BLEOMICINA; INIBIDORES DE TOPOISOMERASES; ETOPOSIDA; AGENTES ALQUILANTES; CICLOFOSFAMIDA; IFOSFAMIDA; CISPLATINA; BUSULFANO; ALCALOIDES DA VINCA; PACLITAXEL; DOCETAXEL; ANTIMETABOLICOS; 5-FLUOROURACIL; CAPECITABINA; FLUDARABINA; MODIFICADORES DA RESPOSTA BIOLOGICA; INTERFERON; INTERLEUCINA-2; ACIDO TRANS-RETINOICO; TRIOXIDO DE ARSENIO; ANTIBIOTICOS; TRASTUZUMABE; RITUXIMABE; BEVACIZUMABE; ALEMTUZUMABE; CETUXIMABE; INIBIDORES DA TIROSINA QUINASE; HORMONIOS |